Calamus Root Glycerite Liquid Extract
Also known as: Calamus, Sweet Flag, Vacha, Calamus Root Glycerite Liquid Extract, Acorus calamus
Overview
Acorus calamus root glycerite liquid extract is an alcohol-free, water-glycerin based extract derived from the dried root or rhizome of the Acorus calamus plant. It is traditionally utilized in Ayurvedic and other traditional medicine systems for its purported benefits in neurological, metabolic, and digestive health. The glycerite form is specifically chosen to preserve the plant's bioactive compounds without the use of alcohol, making it suitable for individuals who may be sensitive to alcohol or prefer alcohol-free preparations. Key characteristics of Acorus calamus include the presence of bioactive compounds such as β-asarone, α- and β-shyobunone, and other sesquiterpenes, which are believed to contribute to its pharmacological effects. While preclinical research suggests potential for antidiabetic, anti-obesity, antioxidant, and antimicrobial applications, human clinical trials, especially high-quality randomized controlled trials, are limited. Therefore, the overall research maturity is moderate, with evidence primarily stemming from in vitro and in vivo (animal) studies.
Benefits
Calamus root extract shows promising, primarily preclinical, evidence for several health benefits: - **Antidiabetic Effects:** Studies in diabetic mice have shown that *A. calamus* ethyl acetate fraction significantly reduces blood glucose levels and increases insulin secretion and GLP-1. It also demonstrates in vitro α-glucosidase inhibition, suggesting a potential role in glycemic control. The strength of evidence is moderate, based on animal and in vitro studies. - **Anti-obesity Effects:** β-Asarone, a compound from *A. calamus*, has been shown to reduce weight gain, improve glucose tolerance, and lower cholesterol in high-fat diet-induced obese rats. The aqueous extract also inhibited pancreatic lipase activity, indicating potential for lipid-lowering. Evidence quality is moderate, derived from preclinical models. - **Antioxidant Activity:** The essential oil of *A. calamus* exhibits strong free radical scavenging activity, as demonstrated by in vitro assays. This suggests potential for protecting cells from oxidative stress. The evidence is moderate, based on in vitro studies. - **Neuroprotective and Cognitive Effects:** Traditionally used for neurological conditions, some preclinical evidence supports neuroprotective effects. However, high-quality human trials are lacking, making the evidence strength low. - **Antimicrobial and Anti-HIV:** Extracts have shown inhibitory effects on HIV-1 reverse transcriptase and demonstrated antibacterial and antifungal activities in vitro. The evidence is low, based on in vitro findings.
How it works
The therapeutic effects of *Acorus calamus* are attributed to its diverse array of bioactive compounds, including β-asarone, α- and β-shyobunone, and other sesquiterpenes. These compounds modulate multiple biological pathways. For instance, they are believed to enhance insulin secretion and GLP-1 release, thereby improving glucose metabolism. They also inhibit key enzymes like α-glucosidase and pancreatic lipase, which can reduce the absorption of carbohydrates and fats, respectively. The antioxidant activity is primarily through free radical scavenging, protecting cells from oxidative damage. In obesity models, β-asarone has been shown to modulate adipocyte metabolism and inflammatory adipokines. While specific absorption and bioavailability data for glycerite extracts are not well characterized, glycerin-based extracts are generally known to preserve both water-soluble and some lipophilic constituents, allowing for their systemic action.
Side effects
The overall safety of *Acorus calamus* in humans, particularly in the glycerite liquid extract form, is not well established due to limited clinical data. A significant safety concern revolves around β-asarone, a major constituent, which has demonstrated potential carcinogenicity in high doses in animal studies. Consequently, regulatory agencies in various regions limit the β-asarone content in food and supplements. Common side effects are not well documented in human studies, though traditional use suggests low acute toxicity at typical doses. However, due to the lack of robust clinical trials, the full spectrum of potential adverse reactions remains unknown. Drug interactions and contraindications are also not well studied; therefore, caution is advised, especially for individuals taking antidiabetic medications, as *A. calamus* may have additive glucose-lowering effects. Furthermore, due to insufficient safety data, *Acorus calamus* should be avoided by special populations, including pregnant and lactating women, and children.
Dosage
There is no standardized or clinically established dosing guideline for *Acorus calamus* root glycerite liquid extract in humans. Preclinical studies in animals have utilized doses in the range of 100-200 mg/kg, but these animal doses do not directly translate to human equivalent doses, which remain undefined. Traditional use of *Acorus calamus* varies widely in dosage, and these traditional practices often lack the precision and standardization required for modern supplement recommendations. Clinical trials with defined and validated doses are currently lacking. Information regarding optimal timing of administration, absorption factors specific to glycerite extracts, and upper safety limits or thresholds for human consumption is not reported in the available research. Due to the safety concerns associated with β-asarone and the absence of clear human dosing data, caution is strongly advised, and use should ideally be under the guidance of a qualified healthcare professional.
FAQs
Is Calamus Root Glycerite safe?
Safety data for Calamus Root Glycerite in humans are limited. Concerns exist due to β-asarone, a compound found in Calamus, which has shown potential carcinogenicity in high doses in animal studies. Caution is warranted.
Does it help with diabetes?
Preclinical studies in animals suggest Calamus may help lower blood glucose and improve insulin secretion. However, human clinical trials are needed to confirm these effects and establish efficacy for diabetes management.
How fast do benefits appear?
Animal studies show effects within days to weeks, but there is no human data to indicate how quickly benefits might appear. Individual responses can vary significantly.
Is alcohol-free extract less effective?
The glycerite form is designed to preserve bioactive compounds without alcohol. Its effectiveness depends on the quality of extraction and the specific compounds retained, which can vary by product.
Research Sources
- https://pmc.ncbi.nlm.nih.gov/articles/PMC7230970/ – This review, including animal studies, indicates that *A. calamus* ethyl acetate fraction reduced blood glucose, increased insulin and GLP-1, inhibited α-glucosidase and pancreatic lipase, and showed antioxidant and anti-obesity effects in rodents. The study highlights promising preclinical findings but notes the absence of human randomized controlled trials.
- https://www.medtextpublications.com/open-access/a-review-on-acorus-calamus-linn-1447.pdf – This narrative review discusses how *A. calamus* extract improved glucose tolerance, lipid profile, and pancreatic histology in STZ-diabetic rats. It also reported in vitro anti-HIV and antimicrobial activity. The review is based on preclinical data and lacks human clinical trials.